Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.
The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.
'Maharashtra Maritime Summit 2025 Charts Path To Global Shipping Hub,' Says CM Fadnavis
Maharashtra: Ratnagiri Wins Gold At ODOP Awards 2024 For Alphonso Mango Excellence
Maharashtra DyCM Eknath Shinde Assures Cabinet Decision To Slash Premium For Land Conversion In Nagari Nivara Colony
Bitterness On Display As Uddhav, Shinde Trade Barbs During Ambadas Danve’s Farewell In Council
